Buy Veklury Remdesivir Lyophilized Powder

Veklury (Remdesivir Lyophilized Powder) is an antiviral medication supplied in 100mg x 20ml vials, designed for intravenous administration. It is commonly used in clinical settings for managing certain viral infections. Store between 2-8°C to maintain potency.

Strength

100mg x 20ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Gilead Sciences

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Veklury is primarily used to treat viral infections in hospitalized patients under medical supervision. It works by interfering with viral replication, supporting the body's ability to manage infection. The lyophilized powder form allows for reconstitution prior to intravenous use. It is not intended for self-administration or unsupervised use.

Side Effects

After administration, patients may experience effects related to the underlying condition being treated. Some individuals report mild reactions at the injection site, such as redness or discomfort. General systemic effects like fatigue or headache can occur but vary by patient. These are not guarantees of therapeutic outcome.

Precautions & Warnings

Veklury should be handled with care, following sterile techniques to prevent contamination. It must be stored refrigerated between 2-8°C and protected from light. Healthcare professionals should assess patient suitability before administration. Do not use if the solution is discolored or contains particles.

Avoid Interactions

Caution is advised when combining Veklury with other medications metabolized by the liver, as interactions may alter drug levels. Certain drugs, including some antivirals or immunosuppressants, may require dose adjustments. Alcohol use should be discussed with a healthcare provider before treatment. Always disclose all medications to your clinician.

References

Frequently Asked Questions

Veklury is used to treat certain viral infections in hospitalized patients under medical supervision.

Veklury is supplied as a lyophilized powder for reconstitution and intravenous use by healthcare professionals.

No, Veklury must be stored refrigerated between 2-8°C to maintain its stability and effectiveness.

Common effects may include mild reactions at the injection site or general symptoms like fatigue or headache.

No, Veklury requires a prescription and should only be administered by qualified healthcare providers.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.